Showing results (921-930 of 1,074) with videos related to

Sort By:
Pageof 108
Communications Biology|November 2, 2021
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recyclingAlexander N Kapustin, Paul Davey, David Longmire, et al.
Haematologica|October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosisJohn O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Blood|August 24, 2012
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemiaJerald P Radich, Kenneth J Kopecky, Frederick R Appelbaum, et al.
British Journal of Haematology|June 8, 2004
Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunctionBritta Fricke, Helen G Jarvis, Cecil D L Reid, et al.
Frontiers in Physiology|August 9, 2023
Ingested histamine and serotonin interact to alter Anopheles stephensi feeding and flight behavior and infection with Plasmodium parasitesTaylor A Coles, Anna M Briggs, Malayna G Hambly, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymesOscar M Saavedra, Ljubomir Isakovic, David B Llewellyn, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitorsLjubomir Isakovic, Oscar M Saavedra, David B Llewellyn, et al.
Cell Reports Methods|February 23, 2023
Toward real-world automated antibody design with combinatorial Bayesian optimizationAsif Khan, Alexander I Cowen-Rivers, Antoine Grosnit, et al.
Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.
Pageof 108